Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Pfizer Inc
PFE
Alternate Symbol(s):
N.PFE
Healthcare
Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the...
Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its Oncology products include Ibrance, Xtandi, Inlyta, Bosulif, Lorbrena, Braftovi, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio and Tivdak. Its primary care products include Eliquis, Nurtec ODT/Vydura, Comirnaty, the Prevnar family, Abrysvo, FSME/IMMUN-TicoVac, Paxlovid and Lucira by Pfizer. Its specialty care products include Xeljanz, Enbrel (outside the U.S. and Canada), Inflectra, Cibinqo, Litfulo, Vyndaqel family, Genotropin, Sulperazon, Zavicefta, Medrol and Panzyga.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NYSE:PFE)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on May 03, 2024 4:47pm
@ the Bell: TSX powers through to close week higher
Canada’s main stock index inched up on Friday. The only drag on the TSX was a drop in the energy sector while mining led gains.
read article.
(117)
•••
ecolo101
X
View Profile
View Bullboard History
Post by
ecolo101
on May 03, 2024 9:20am
Stock price Moving average
Here are the stats. We are slowly but surely walking toward the 200 MDA. Period Moving Average Price Change 20-Day 26.10 +0.43
...more
Viva Gold: Multiple High-Grade Gold Hits Includes 90 Meters at 2.0 gpt Gold
posted May 05, 2024 9:00am by
Viva Gold Corp.
-
|
TG2409 (21.3 meters at 5.1 gpt Au) was drilled as an approximate 40-meter offset to the west of TG2211 (57.9-meters at 5.0 gpt Au commencing at 40 meters depth). TG2408 (18.3 meters at 4.4 gpt Au). TG2407 (89.9 meters@ 2.0 gpt Au). TG2404 (36.6 Meters @ 3.3 gpt Au). “Many geologists go their whole careers without seeing drill results like these ...read more
(117)
•••
ecolo101
X
View Profile
View Bullboard History
Post by
ecolo101
on May 02, 2024 2:31pm
Q1 results beat expectations
PFE Pfizer Inc. Q1 $0.82 Beat by $0.31 PFE Pfizer Inc. Q1
...more
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on May 02, 2024 8:22am
Buzz on the Bullboards: The top stocks in energy, mining and EVs
While energy gains propel the TSX, industrials get attention from the EV market and investors navigate another week of mining sector activity.
read article.
(117)
•••
ecolo101
X
View Profile
View Bullboard History
Post by
ecolo101
on May 01, 2024 2:22pm
Trading volume today
We are way higher than the average 42 millions shares per day we are at 55 million and keep increasing. this is very good with a 6% stock price increase. we have the real W shape and it is going up
...more
(117)
•••
ecolo101
X
View Profile
View Bullboard History
Post by
ecolo101
on May 01, 2024 10:26am
Excellent Quarterly report
And here we go, up up and probably up... and ex dividend date coming soon. glta dyodd
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on May 01, 2024 6:45am
New Press Release - Pfizer Reports First-Quarter 2024 Results
Solid First-Quarter Results Reflect Continued Growth of Key Products and Progress in Executing 2024 Priorities First-Quarter 2024 Revenues of $14.9 Billion Expected Decline in Comirnaty(1) and Paxlovid Revenues Drove a Year-Over-Year Operational Decrease in Revenues of 19% Excluding...
read article.
(117)
•••
ecolo101
X
View Profile
View Bullboard History
Post by
ecolo101
on Apr 30, 2024 8:55pm
1998 value , $25
Difficult to understand and on top maximum inflation lately. So if you put it in constant dollar, this is a disaster. Bagholders are suffering and they need a vaccine... what will trigger a small leg
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 29, 2024 6:40pm
New Press Release - TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer
Company AnnouncementFull approval based on global Phase 3 study demonstrating overall survival benefit of TIVDAK compared to chemotherapyTIVDAK is the first antibody-drug conjugate in this patient population to have positive overall survival data Genmab A/S (Nasdaq: GMAB) and Pfizer Inc. (NYSE...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 29, 2024 6:40pm
New Press Release - FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer
TIVDAK is the first antibody-drug conjugate (ADC) to have positive overall survival data for patients with previously treated recurrent or metastatic cervical cancerConversion to full approval from accelerated approval is based on positive results from global Phase 3 study demonstrating overall...
read article.
(117)
•••
ecolo101
X
View Profile
View Bullboard History
Post by
ecolo101
on Apr 29, 2024 10:19am
Let’s hope for a W shape
Starting right now.... Pfizer should do way better than this on stock price. We should be around $30 by now... dyodd
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 29, 2024 6:45am
New Press Release - Pfizer Highlights Progress in Accelerating Breakthrough Cancer Medicines at ASCO 2024 Annual Meeting
More than 50 abstracts, including 11 oral presentations, span Pfizer’s robust portfolio of approved and pipeline therapies across its key tumor areas and core scientific modalitiesNew five-year progression-free survival data for LORBRENA® (lorlatinib) in first-line ALK-positive advanced lung...
read article.
(117)
•••
ecolo101
X
View Profile
View Bullboard History
Post by
ecolo101
on Apr 26, 2024 6:35pm
Market rebound today
And PFE is doing nothing. This is definitely not good...people don't want to take any chance so think about big institutions? Ouch! looking at option deals over the next few weeks
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 26, 2024 6:46am
New Press Release - U.S. FDA Approves Pfizer's BEQVEZ(TM) (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B
A one-time dose of BEQVEZ has reduced bleeds post-treatment compared to standard of care with a median of zero bleeds (range 0 to 19) after up to three years of follow-up, providing sustained bleed protection and potentially avoiding years of treatment burden with prophylaxis for many patients...
read article.
(485)
•••
barneyj44
X
View Profile
View Bullboard History
Comment by
barneyj44
on Apr 25, 2024 11:57pm
RE:The dividend of $0.42
Yeah Pfe has been a disaster. I'm done averaging down on this one. Seems there getting lawsuits thrown at them every second day.
(117)
•••
ecolo101
X
View Profile
View Bullboard History
Post by
ecolo101
on Apr 25, 2024 5:08pm
The dividend of $0.42
Does not cover today's loss nothing else to add dyodd
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 24, 2024 4:37pm
New Press Release - Pfizer Declares Second-Quarter 2024 Dividend
Board of Directors approves quarterly cash dividend of $0.42 per share Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.42 second-quarter 2024 dividend on the company’s common stock, payable June 14, 2024, to holders of the Common Stock of record at the close of...
read article.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Significant New Silver Discoveries in the Famous Keno Hill District in the Yukon
An Opportunity to Join Pulsar Helium on the Ground in Minnesota for a Historic Reservoir Flow Test